About The Journal of Rheumatology First published in 1974, The Journal of Rheumatology is a monthly international serial edited by Earl D. Silverman. The Journal features peer-reviewed research articles on clinical subjects from scientists working in rheumatology and related fields, with the support of our esteemed Editorial Committee and Editorial Board. According to The Canadian Essential Journal Study, The Journal of Rheumatology is ranked among the top 3 essential publications for rheumatology. In fact, 74% of rheumatologists consider it an essential journal, making it the top journal in the specialty. The Journal publishes timely clinical research papers every month, both in print and online. With over 22,000 citations per year, The Journal of Rheumatology’s influence and reach extends to over 3600 subscribers globally and to all active members of the Canadian Rheumatology Association, including rheumatology residents and trainees. With over 1600 submissions a year from over 50 countries, each issue of The Journal of Rheumatology includes original clinical research articles, metaanalyses, systematic reviews, editorials, historical vignettes, case reports, and letters by world-renowned experts studying drug therapy, patient-reported outcomes, discovery of therapeutic targets in the treatment of rheumatic diseases such as RA, AS, PsA, OA, and other rheumatic and musculoskeletal diseases. CLINICAL HIGHLIGHTS FOR THE RHEUMATOLOGIST Beginning in 2012, a bimonthly print edition was launched in the USA and distributed to 4200 rheumatologists, called Clinical Highlights for the Rheumatologist (CHR). Articles that appear in CHR have been selected from the most recent issues of The Journal of Rheumatology by the Editor-in-Chief for their high interest to the clinical rheumatologist. Address: The Journal of Rheumatology, 365 Bloor Street East, Suite 901, Toronto, ON M4W 3L4 Canada; Telephone (416) 967-5155; FAX (416) 967-7556; E-mail: jrheum@jrheum.com